comparemela.com

Latest Breaking News On - Cancer panels - Page 1 : comparemela.com

Genomic Cancer Panel and Profiling Market Set to Reach

Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) The

United statesRoche ltdLaboratory corporation of america holdingsThermo fisher scientific incDanaher corporation integratedGenomic cancer panelIllumina incInvitae corporationTechnologies incAgilent technologies incCaris life sciencesCancer panel typeGenecast biotechnology co ltdCancer panel typesSciences corporationCancer panel

Global Genomic Cancer Panel & Profiling Market Report

Dublin, Dec. 20, 2023 (GLOBE NEWSWIRE) The

United statesSouth koreaTheragen bioAgilent technologies incCompany profilesCommon hereditary cancers panelSciences corpSciences corporationGenecast biotechnology coGenomic cancer panelThermo fisher scientific incInvitae corporationDanaher corporation integratedTechnologies incPillar biosciences incOncocyte corporation

Olaparib Did Not Improve PFS2, OS in SOLO3 Trial

Olaparib did not improve overall survival or the time from randomization to second progression or death, when compared with chemotherapy.

United statesSutro biopharmaRichard pensonWiley blackwellRoche pharmaWolters kluwer healthArray biopharma incVascular biogenics ltdTesaro incEisai incMerck coGenentech incElsevier ltdCancer therapy advisorMassachusetts general hospitalCancer panels

Outlook on the Genomic Cancer Panel and Profiling Global

Dublin, Jan. 28, 2022 (GLOBE NEWSWIRE) The "Genomic Cancer Panel and Profiling Markets by Cancer, by Application, by Tissue and by Gene Type with.

United statesMiltenyi biotecYourgene elucigeneAgilent dakoQiagen gmbhSysmex inosticsBristol myers squibbPerkin elmerSiemens healthineersAcademic research labCastle biosciences incTesting labPublic nationalCentral labTechnology developmentSinglera genomics inc

vimarsana © 2020. All Rights Reserved.